Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by MAXIME DOUGADOS
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients With Rheumatoid Arthritis Receiving Background Methotrexate: A 5-Year Extended Phase IIB Study
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Related publications
The Efficacy and Safety of Abatacept in Rheumatoid Arthritis
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment With Abatacept in Patients With Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Efficacy, Safety, and Tolerability of Abatacept in the Management of Rheumatoid Arthritis
Open Access Rheumatology: Research and Reviews
Rheumatology
Efficacy and Safety of Tofacitinib in Japanese Patients With Rheumatoid Arthritis by Background Methotrexate Dose: A Post-Hoc Analysis of Clinical Trial Data
Modern Rheumatology
Medicine
Rheumatology
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes From the 24-Month Phase 3 ORAL Scan Study
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis
Postgraduate Medical Journal
Medicine
Better Retention of Abatacept Is Associated With High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients With Rheumatoid Arthritis
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
SAT0172 Long-Term Efficacy With 5-Year-Radiographic Results and Safety of Sarilumab in Combination With Csdmards in Patients With Rheumatoid Arthritis
Evaluation of Abatacept Administered Subcutaneously in Adults With Active Rheumatoid Arthritis: Impact of Withdrawal and Reintroduction on Immunogenicity, Efficacy and Safety (Phase Iiib ALLOW Study)
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics